This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Matsumura, S. O.
Right arrow Articles by Simor, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Matsumura, S. O.
Right arrow Articles by Simor, A. E.

 Previous Article  |  Next Article 

Antimicrobial Agents and Chemotherapy, November 1999, p. 2776-2779, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Synergy Testing of Vancomycin-Resistant Enterococcus faecium against Quinupristin-Dalfopristin in Combination with Other Antimicrobial Agents

S. O. Matsumura,1 L. Louie,1 M. Louie,1,2 and A. E. Simor1,2,*

Department of Microbiology, SD Laboratory Services, Sunnybrook and Women's College Health Sciences Centre, North York,1 and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto,2 Ontario, Canada

Received 11 February 1999/Returned for modification 31 May 1999/Accepted 29 August 1999

Using checkerboard and time-kill assays, we evaluated the in vitro activity of quinupristin-dalfopristin (RP 59500) alone and in combination with five other antimicrobial agents against 12 clinical strains of vancomycin-resistant Enterococcus faecium (VREF). In time-kill studies, six VREF strains exhibited synergism with the combination of quinupristin-dalfopristin and doxycycline and three exhibited synergism with quinupristin-dalfopristin plus ampicillin-sulbactam. Combinations of quinupristin-dalfopristin with these and other agents warrant further clinical evaluation for the treatment of serious VREF infections.


* Corresponding author. Mailing address: Department of Microbiology, Sunnybrook and Women's College Health Sciences Centre, B121-2075 Bayview Ave., North York, Ontario, Canada M4N 3M5. Phone: (416) 480-4549. Fax: (416) 480-6845. E-mail: andrew.simor{at}sunnybrook.on.ca.


Antimicrobial Agents and Chemotherapy, November 1999, p. 2776-2779, Vol. 43, No. 11
0066-4804/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.



This article has been cited by other articles:

  • Bethea, J A., Walko, C. M, Targos, P. A (2004). Treatment of Vancomycin-Resistant Enterococcus with Quinupristin/Dalfopristin and High-Dose Ampicillin. The Annals of Pharmacotherapy 38: 989-991 [Abstract] [Full Text]  
  • Brown, J., Freeman, B. B III (2004). Combining Quinupristin/Dalfopristin with Other Agents for Resistant Infections. The Annals of Pharmacotherapy 38: 677-685 [Abstract] [Full Text]  
  • Allen, G. P., Cha, R., Rybak, M. J. (2002). In Vitro Activities of Quinupristin-Dalfopristin and Cefepime, Alone and in Combination with Various Antimicrobials, against Multidrug-Resistant Staphylococci and Enterococci in an In Vitro Pharmacodynamic Model. Antimicrob. Agents Chemother. 46: 2606-2612 [Abstract] [Full Text]  
  • Eliopoulos, G. M., Wennersten, C. B. (2002). Antimicrobial Activity of Quinupristin-Dalfopristin Combined with Other Antibiotics against Vancomycin-Resistant Enterococci. Antimicrob. Agents Chemother. 46: 1319-1324 [Abstract] [Full Text]  
  • Raad, I., Hachem, R., Hanna, H., Girgawy, E., Rolston, K., Whimbey, E., Husni, R., Bodey, G. (2001). Treatment of Vancomycin-Resistant Enterococcal Infections in the Immunocompromised Host: Quinupristin-Dalfopristin in Combination with Minocycline. Antimicrob. Agents Chemother. 45: 3202-3204 [Abstract] [Full Text]